Article
Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma.
Oncoimmunology - 1 Jan 2021
You Hua, Xu-Monette Zijun Y, Wei Li, Nunns Harry, Nagy Máté L, Bhagat Govind, Fang Xiaosheng, Zhu Feng, Visco Carlo, Tzankov Alexandar, Dybkaer Karen, Chiu April, Tam Wayne, Zu Youli, Hsi Eric D, Hagemeister Fredrick B, Huh Jooryung, Ponzoni Maurilio, Ferreri Andrés J M, Møller Michael B, Parsons Benjamin M, Van Krieken J Han, Piris Miguel A, Winter Jane N, Li Yong, Au Qingyan, Xu Bing, Albitar Maher, Young Ken H
Abstract excerpt
Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma with high mutation burdens but a low response rate to immune checkpoint inhibitors. In this study, we performed targeted next-generation sequencing and fluorescent multiplex immunohistochemistry, and investigated the clinical significance and immunological effect of mutation numbers in 424 DLBCL patients treated with standard...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
